Venture Capital · New York (United States) · Founded 2017
Dynamk Capital invests in innovative tools and technologies that are critical for the discovery, development and production of life-saving therapies. We partner with life science visionaries whose market-defining ideas are shaping the future of how therapeutics are being developed, increasing access for patients, and reducing costs.
Seed, Series A, Series B
BioTech, development and production of life-saving therapies, services for the discovery, technologies, tools
Virica Biotech, Lucid Scientific, Alpenglow Biosciences, CellFE Biotech, Curibio, RoosterBio, Vectron Biosolutions, Vernal Biosciences, CellFE Biotech, Envisagenics, RESIPHER, Xcell Bioscience